Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Murray

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
JAMA Oncology|November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabReva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
Journal for Immunotherapy of Cancer|July 29, 2020
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled studyChiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, et al.
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.
JAMA Oncology|June 8, 2018
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast CancerNaoko Matsuda, Xiaoping Wang, Bora Lim, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
JAMA Oncology|November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabReva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
Journal for Immunotherapy of Cancer|July 29, 2020
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled studyChiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, et al.
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.
JAMA Oncology|June 8, 2018
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast CancerNaoko Matsuda, Xiaoping Wang, Bora Lim, et al.
Pageof 7